Legflow RX/OTW

Added Dec 12, 2017

Manufactured by BVM Medical

Editor Rating

info

User Rating

info
Add your Rating

Categorised under: Interventional Radiology > Vascular > Balloons

Description

From BVM Medical

 

Paclitaxel Releasing Peripheral Balloon Dilatation Catheter

For the safest SFA & BTK revascularization therapy! The LEGFLOW balloon drug coating quality is a major step beyond contemporary first and second generation DCB coatings. LEGFLOW RX/OTW provides a 100% anti-proliferative vessel wall protection,and promotes rapid healing after mechanical balloon angioplasty.

The best option for SFA/popliteal de novo and restenotic lesions.

Treating peripheral artery disease (PAD) in the superficial femoral artery (SFA) is a difficult challenge. The anatomy is very dynamic and contains complex lesions, but also patient comorbidities such as diabetes require the clinically most-effective therapy. The new LEGFLOW Paclitaxel-releasing peripheral balloon dilatation catheter provides a clinically most successful treatment of peripheral artery disease, and ensures a long-term vessel patency.Treating peripheral artery disease (PAD) in the superficial femoral artery (SFA) is a difficult challenge. The anatomy is very dynamic and contains complex lesions, but also patient comorbidities such as diabetes require the clinically most-effective therapy. The new LEGFLOW Paclitaxel-releasing peripheral balloon dilatation catheter provides a clinically most successful treatment of peripheral artery disease, and ensures a long-term vessel patency.

The new treatment of BTK lesions and critical limb ischemia! LEGFLOW shows promising early clinical study results.

The rate of recurrent stenosis after PTA and stenting is higher in the below-the-knee area than in femoropopliteal procedures. The absence of metal struts makes the LEGFLOW balloon dilatation suitable for treating long lesions, especially in small diameter vessels and areas in which flexion and compression of the stent may occur and result in stent fractures, particularly in the below-the-knee area. Thanks to the new stable ‘SAFEPAX’ PTX coating technology, the treatment of critical limb ischemia patients appears as safe as POBA angioplasty.

 

Have you used this device?

Your opinion matters to others - rate this device or add a comment

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.